Exposure to pro-oxidative stressors, including therapeutic agents, has been shown to generate oxidized lipids with platelet-activating factor (PAF) agonists’ activity from various cell types, including tumor cells [1,2,3,4,5,6,7]. This evidence concerns the gene PCLAF and neoplasm.